Food and drug administration Recommends All Bloodstream Donations Be Tested for Zika

 

FDA wants blood donations tested for Zika virus

Video taken from the channel: WWLP-22News


 

FDA recommends all blood donations test for ZIka

Video taken from the channel: WJBF


 

FDA recommends all blood donated tested for Zika

Video taken from the channel: KGUN9


 

Screening U.S. Blood Donations for Zika

Video taken from the channel: NEJMvideo


 

Zika Triggers New Concerns Over Blood Donations

Video taken from the channel: Wall Street Journal


 

Dr. Justin Kreuter discusses blood donations and Zika

Video taken from the channel: Mayo Clinic


 

FDA: Screen all blood donations for Zika

Video taken from the channel: CNN


The FDA first issued guidance on Feb. 16 recommending that only areas with active Zika virus transmission screen donated Whole Blood and blood components for Zika virus. Donated blood is already being tested in Florida and Puerto Rico, as well as in other areas, FDA officials said Friday, and expanded testing should lower the risk of Zika spreading even further. CHICAGO/TAMPA, Fla. (Reuters) The U.S. Food and Drug Administration recommended on Friday that all blood donated in the United States and its territories be tested for Zika virus, as it moves to.

CHICAGO/TAMPA, Fla., Aug 26 (Reuters) The U.S. Food and Drug Administration recommended on Friday that all blood donated in the United States and its territories be tested for Zika virus. H ealth authorities are recommending that all donated blood for the United States and its territories be tested for the Zika virus. Previously, the U.S.

Food and Drug Administration (FDA) had. Blood donations get tested for a range of other illnesses, including hepatitis B and C, HIV and syphilis. The FDA also recommends testing for West Nile Virus and Chagas disease, which is.

The revised guidance explains the basis for the FDA’s determination that pooled testing of donations using a screening test licensed for such use by the FDA is a sufficient method for complying. CHICAGO/TAMPA, Fla., Aug 26 (Reuters) The U.S. Food and Drug Administration recommended on Friday that all blood donated in the United States and its territories be tested for Zika.

The revised guidance explains the basis for the FDA’s determination that pooled testing of donations using a screening test licensed for such use by the FDA is a sufficient method for complying. The revised guidance explains that, in order to comply with applicable testing regulations, blood establishments must continue to test all donated Whole Blood and blood components for Zika virus.

List of related literature:

New guidelines by the U.S. Food and Drug Administration (FDA) call for testing blood donors in areas where active Zika virus transmission has occurred.

“Ferri's Clinical Advisor 2019 E-Book: 5 Books in 1” by Fred F. Ferri
from Ferri’s Clinical Advisor 2019 E-Book: 5 Books in 1
by Fred F. Ferri
Elsevier Health Sciences, 2018

Under 21 CFR 630.10(a), if a donor volunteers a recent history of Zika infection, you must not collect blood or blood components from that individual.

“Linne & Ringsrud's Clinical Laboratory Science E-Book: Concepts, Procedures, and Clinical Applications” by Mary Louise Turgeon
from Linne & Ringsrud’s Clinical Laboratory Science E-Book: Concepts, Procedures, and Clinical Applications
by Mary Louise Turgeon
Elsevier Health Sciences, 2018

In October 2017, the FDA approved the first Zika test for screening blood donations.

“Hunter's Tropical Medicine and Emerging Infectious Diseases E-Book” by Edward T Ryan, David R Hill, Tom Solomon, Timothy P Endy, Naomi Aronson
from Hunter’s Tropical Medicine and Emerging Infectious Diseases E-Book
by Edward T Ryan, David R Hill, et. al.
Elsevier Health Sciences, 2019

Universal testing for the Zika virus is now recommended on all blood and blood components in the United States (Pifer & Hicks, 2017).

“Skills for Midwifery Practice Australia & New Zealand edition” by Sara Bayes, Sally-Ann de-Vitry Smith, Robyn Maude
from Skills for Midwifery Practice Australia & New Zealand edition
by Sara Bayes, Sally-Ann de-Vitry Smith, Robyn Maude
Elsevier Health Sciences APAC, 2018

increased laboratory capacity to test for Zika virus infection (including blood donor screening), implementation of enhanced surveillance systems, and prevention activities focused on pregnant women.

“Public Health Nursing: Practicing Population-Based Care” by Truglio-Londrigan, Sandra Lewenson
from Public Health Nursing: Practicing Population-Based Care
by Truglio-Londrigan, Sandra Lewenson
Jones & Bartlett Learning, 2017

In multiparous donors from the United States, the incidence of anti-HLA antibodies is approximately 25% and, therefore, policies to exclude high-risk donors can potentially adversely affect the supply of blood products.

“The Washington Manual of Oncology” by Ramaswamy Govindan, Washington University (Saint Louis, Mo.). School of Medicine
from The Washington Manual of Oncology
by Ramaswamy Govindan, Washington University (Saint Louis, Mo.). School of Medicine
Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008

For that reason, WNV testing kits for WNV antibodies are routinely performed on all donated blood.

“Mosby's Manual of Diagnostic and Laboratory Tests E-Book” by Kathleen Deska Pagana, Timothy J. Pagana
from Mosby’s Manual of Diagnostic and Laboratory Tests E-Book
by Kathleen Deska Pagana, Timothy J. Pagana
Elsevier Health Sciences, 2009

Most recently (August 2016), the implementation of universal, individual donation NAT for Zika virus RNA has been required for all blood collected in the United States.

“Hematology: Basic Principles and Practice E-Book” by Leslie E. Silberstein, John Anastasi, Ronald Hoffman, Edward J. Benz, Helen Heslop, Jeffrey Weitz
from Hematology: Basic Principles and Practice E-Book
by Leslie E. Silberstein, John Anastasi, et. al.
Elsevier Health Sciences, 2017

For that reason, WNV testing for WNV antibodies is routinely performed on all donated blood.

“Mosby's Canadian Manual of Diagnostic and Laboratory Tests E-Book” by Kathleen Deska Pagana, Timothy J. Pagana, Sandra A. Pike-MacDonald
from Mosby’s Canadian Manual of Diagnostic and Laboratory Tests E-Book
by Kathleen Deska Pagana, Timothy J. Pagana, Sandra A. Pike-MacDonald
Elsevier Health Sciences, 2012

The FDA’s response to the 2015 to 2016 Zika virus outbreak was similarly swift—the blood supply was immediately shifted from areas with low risk of infections to areas of known infection; authorization for screening tests was issued

“Miller's Anesthesia, 2-Volume Set E-Book” by Michael A. Gropper, Ronald D. Miller, Lars I. Eriksson, Lee A Fleisher, Jeanine P. Wiener-Kronish, Neal H Cohen, Kate Leslie
from Miller’s Anesthesia, 2-Volume Set E-Book
by Michael A. Gropper, Ronald D. Miller, et. al.
Elsevier Health Sciences, 2019

Oktay Kutluk

Kutluk Oktay, MD, FACOG is one of the world's foremost experts in fertility preservation as well as ovarian stimulation and in vitro fertilization for infertility treatments. He developed and performed the world's first ovarian transplantation procedures as well as pioneered new ovarian stimulation protocols for embryo and oocyte freezing for breast and endometrial cancer patients.

Mail: [email protected]
Telephone: +1 (877) 492-3666

Biography: https://medicine.yale.edu/profile/kutluk_oktay/
Bibliography: oktay_bibliography

View all posts

1 comment

Your email address will not be published. Required fields are marked *

  • B.S.

    If they want to screen donations, they want the rest of us to PAY for it, which is a scam to make them more money. On top of that, they will be screening for lots of other stuff also, including putting your DNA in a database.